Author:
Gutzman J H,Rugowski D E,Nikolai S E,Schuler L A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference45 articles.
1. Bjornstrom L, Sjoberg M . (2002). STAT as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16: 2202–2214.
2. Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ . (1995). Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221: 706–718.
3. Brockman JL, Schroeder MD, Schuler LA . (2002). Prolactin activates the cyclin D1 promoter via the JAK2-STAT pathway. Mol Endocrinol 16: 774–784.
4. Bromberg J . (2002). Stat proteins and oncogenesis. J Clin Invest 109: 1139–1142.
5. Buettner R, Mora LB, Jove R . (2002). Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945–954.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献